EFFECT OF PLATELET RICH FIBRIN ON WOUND HEALING TIME AFTER REVASCULARIZATION.

IF 0.5 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL
Mijo Mravičić, Ana Adžić-Kapitanović, Andrej Razumić, Marta Bakšić, Vedran Pažur, Tena Magovac, Marko Granić
{"title":"EFFECT OF PLATELET RICH FIBRIN ON WOUND HEALING TIME AFTER REVASCULARIZATION.","authors":"Mijo Mravičić, Ana Adžić-Kapitanović, Andrej Razumić, Marta Bakšić, Vedran Pažur, Tena Magovac, Marko Granić","doi":"10.20471/acc.2025.64.02.21","DOIUrl":null,"url":null,"abstract":"<p><p>One of the most common diseases in vascular surgery is peripheral arterial disease, the last stage of which is critical limb ischemia. It is characterized by rest pain or tissue loss. In most cases, after revascularization, and due to gangrenous changes, it is necessary to perform amputation of a part of the lower limb. After amputation, the wound is bandaged with dressings. In conducting this pilot study, some patients were bandaged with platelet rich fibrin (PRF) in combination with dressings, while the others were treated only with dressings. PRF is a biologic material that is received from blood of the patient. All patients included in the trial had at least 2 out of 3 traversable blood vessels in the lower leg before treatment and underwent femoropopliteal bridging with prosthesis. Patients treated with PRF after revascularization had an average of 5 weeks of wound healing, in contrast to patients treated only with dressings, whose mean wound healing was 8.5 weeks and a proportion of these patients ended up with an extended amputation level. After the study, it is concluded that this type of treatment can be safely used in the treatment of vascular pathology.</p>","PeriodicalId":7072,"journal":{"name":"Acta clinica Croatica","volume":"64 2","pages":"371-379"},"PeriodicalIF":0.5000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12863282/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta clinica Croatica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.20471/acc.2025.64.02.21","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

One of the most common diseases in vascular surgery is peripheral arterial disease, the last stage of which is critical limb ischemia. It is characterized by rest pain or tissue loss. In most cases, after revascularization, and due to gangrenous changes, it is necessary to perform amputation of a part of the lower limb. After amputation, the wound is bandaged with dressings. In conducting this pilot study, some patients were bandaged with platelet rich fibrin (PRF) in combination with dressings, while the others were treated only with dressings. PRF is a biologic material that is received from blood of the patient. All patients included in the trial had at least 2 out of 3 traversable blood vessels in the lower leg before treatment and underwent femoropopliteal bridging with prosthesis. Patients treated with PRF after revascularization had an average of 5 weeks of wound healing, in contrast to patients treated only with dressings, whose mean wound healing was 8.5 weeks and a proportion of these patients ended up with an extended amputation level. After the study, it is concluded that this type of treatment can be safely used in the treatment of vascular pathology.

Abstract Image

Abstract Image

Abstract Image

富血小板纤维蛋白对血运重建后创面愈合时间的影响。
血管外科中最常见的疾病之一是外周动脉疾病,其最后阶段是危急肢体缺血。其特征是静息性疼痛或组织丧失。在大多数情况下,在血运重建术后,由于坏疽的改变,有必要对下肢的一部分进行截肢。截肢后,用敷料包扎伤口。在进行这项初步研究时,一些患者使用富血小板纤维蛋白(PRF)联合敷料进行包扎,而另一些患者仅使用敷料进行治疗。PRF是一种从患者血液中提取的生物材料。所有纳入试验的患者在治疗前下肢至少有3条可穿越血管中的2条,并接受假体股腘桥接。血运重建术后接受PRF治疗的患者平均伤口愈合时间为5周,而仅接受敷料治疗的患者平均伤口愈合时间为8.5周,其中一部分患者最终截肢程度延长。经研究,认为这种治疗方法可安全用于血管病变的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta clinica Croatica
Acta clinica Croatica 医学-医学:内科
CiteScore
1.10
自引率
16.70%
发文量
38
审稿时长
6-12 weeks
期刊介绍: Acta Clinica Croatica is a peer reviewed general medical journal that publishes original articles that advance and improve medical science and practice and that serve the purpose of transfer of original and valuable information to journal readers. Acta Clinica Croatica is published in English four times a year.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书